KATHERINE PATERSON: Open Payments
NPI 1164776548 · GONZALES, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$185 in 8 payments from 5 companies in 2025. Trend: 2023 $646 · 2024 $325 · 2025 $185
Food & beverage: $185
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $55 |
| Lilly USA, LLC | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Amgen Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: Ozempic, ZEPBOUND, BREZTRI, MOUNJARO, OTEZLA, JARDIANCE, FARXIGA.
Industry payments across TX — which companies pay providers there.
